Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 60 2005 054 334.1 |
96 | EP file number | EAKZ | 11 15 3604.1 |
97 | EP publication number | EPN | 2319925 |
54 | Designation/title | TI | Therapeutische Verwendungen von RTP801-Hemmern |
51 | IPC main class | ICM (ICMV) | C12N 15/113 (2010.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 31/713 (2006.01), A61P 11/00 (2006.01), A61P 27/00 (2006.01) |
22 | DE application date | DAT | Aug 16, 2005 |
96 | EP application date | EAT | Aug 16, 2005 |
43 | Date of first publication | OT | May 11, 2011 |
| Date of publication of grant | PET | Jul 25, 2018 |
71/73 | Applicant/owner | INH | Quark Pharmaceuticals, Inc., Fremont, Calif., US; Silence Therapeutics GmbH, 13125 Berlin, DE |
72 | Inventor | IN | Feinstein, Elena, 76305 Rehovot, IL; Kaufmann, Jörg, 13125 Berlin, DE; Giese, Klaus, 13125 Berlin, DE |
74 | Representative | VTR | Hernandez, Yorck, Dipl.-Ing., 82031 Grünwald, DE |
| Address for service | | HERNANDEZ IP, 82031 Grünwald, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 638659 P Dec 22, 2004
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| EP 04019405 Aug 16, 2004
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 604668 P Aug 25, 2004
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 609786 P Sep 14, 2004
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 688943 P Jun 8, 2005
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 601983 P Aug 17, 2004
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 664236 P Mar 22, 2005
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002319925 Searchable text:
EP000002319925 Original document:
EP000002319925B1 Searchable text:
EP000002319925B1 |
43 | Date of first publication | EVT | May 11, 2011 |
| Date of the first transfer into DPMAregister | EREGT | Jun 22, 2011 |
| Date of the (most recent) update in DPMAregister | REGT | May 25, 2022 (Show all update days)(Hide all update days)- May 25, 2022; Apr 17, 2022; Sep 9, 2021; Jul 8, 2021; Dec 5, 2020; Dec 3, 2020; Aug 31, 2020; Sep 7, 2019; Aug 21, 2019; Jul 18, 2019; Jun 13, 2019; Feb 14, 2019; Nov 22, 2018; Oct 18, 2018; Sep 11, 2018; Aug 14, 2018; Jul 12, 2018; Feb 6, 2018; Feb 15, 2013; Sep 22, 2011; Jun 23, 2011
- Historical data not available for this/these date(s)
- Jun 22, 2011
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 5)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Oct 17, 2018 |
| Issue number | HN | 47 |
| Year | PJ | 2018 |
| Publication date | VT | Nov 22, 2018 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | Quark Pharmaceuticals, Inc., Fremont, Calif., US; Silence Therapeutics GmbH, 13125 Berlin, DE |
71/73 | Previous applicant/owner | INHF | Quark Pharmaceuticals, Inc., Fremont, Calif., US, Silence Therapeutics AG, 13125 Berlin, DE |